--- topic: "Hashimoto's Thyroiditis" title: "Natural Management of Hashimoto's Thyroiditis" order: 1 description: "Evidence-based nutritional and lifestyle strategies — selenium, vitamin D, myo-inositol, and dietary changes — that reduce thyroid autoantibodies and support thyroid function" question: "Do selenium and vitamin D help Hashimoto's thyroiditis?" answer: "Selenium and vitamin D probably lower thyroid antibodies in Hashimoto's, but whether that improves symptoms or slows the disease is less certain." actions: - "Ask your doctor to test 25-OH vitamin D and selenium status before supplementing; vitamin D worked best in people deficient at baseline [2]." - "Selenium trials used 100–200 mcg/day; one Brazil nut holds roughly 50–90 mcg, though content varies widely [1]." - "Test for celiac disease (anti-tTG IgA) before any gluten-free trial, because removing gluten falsely normalizes the test." cautions: - "Selenium is toxic in excess; guide supplementation with blood testing (optimal serum level is about 120–150 mcg/L)." - "Excess iodine (seaweed or high-dose iodine supplements) can trigger Hashimoto's flares, especially when selenium is low." - "These approaches support, but do not replace, thyroid hormone medication when it is needed; talk to your doctor before changing it." confidence: 4 confidenceNote: "Meta-analyses for selenium (2,358 people) and vitamin D (862 people) both show lower TPO-Ab; doses and assays varied; gluten-free evidence is one small pilot." evidenceSummary: rctCount: 3 observationalCount: 0 metaAnalysisCount: 4 totalParticipants: "3,000+" replicated: true newestStudyYear: 2024 references: - id: "1" pmid: "38243784" title: "Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials" authors: "Huwiler VV, Maissen-Abgottspon S, Stanga Z, Mühlebach S" year: 2024 journal: "Thyroid" - id: "2" pmid: "38206745" title: "Effects of vitamin D supplementation on autoantibodies and thyroid function in patients with Hashimoto's thyroiditis: A systematic review and meta-analysis" authors: "Tang J, Shan S, Li F, Yun P" year: 2023 journal: "Medicine (Baltimore)" - id: "3" pmid: "28724185" title: "Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto's patients with subclinical hypothyroidism" authors: "Nordio M, Basciani S" year: 2017 journal: "European Review for Medical and Pharmacological Sciences" - id: "4" pmid: "30060266" title: "The Effect of Gluten-Free Diet on Thyroid Autoimmunity in Drug-Naïve Women with Hashimoto's Thyroiditis: A Pilot Study" authors: "Krysiak R, Szkróbka W, Okopień B" year: 2019 journal: "Experimental and Clinical Endocrinology & Diabetes" - id: "5" pmid: "37969187" title: "Therapeutic effect of vitamin D in Hashimoto's thyroiditis: a prospective, randomized and controlled clinical trial in China" authors: "Jiang X, Huang Y, Li Y, Xia Y" year: 2023 journal: "American Journal of Translational Research" - id: "6" pmid: "24224112" title: "Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis" authors: "Nordio M, Pajalich R" year: 2013 journal: "Journal of Thyroid Research" - id: "7" pmid: "39650307" title: "Role of Supplementation with Selenium and Myo-Inositol Versus Selenium Alone in Patients of Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis" authors: "Zuhair V, Sheikh AT, Shafi N, Babar A, Khan A, Sadiq A, Ashraf MA, Nihan K, Hamza M, Khalid B, Haya Fatima S, Arshad MA, Ali E" year: 2024 journal: "Clinical Medicine Insights. Endocrinology and Diabetes" - id: "8" pmid: "37554764" title: "Effect of gluten-free diet on autoimmune thyroiditis progression in patients with no symptoms or histology of celiac disease: a meta-analysis" authors: "Piticchio T, Frasca F, Malandrino P, Trimboli P, Carrubba N, Tumminia A, Vinciguerra F, Frittitta L" year: 2023 journal: "Frontiers in Endocrinology" --- Hashimoto's thyroiditis is the most common autoimmune condition in the world, affecting an estimated 10% of women at some point in their lives. The immune system mistakenly attacks the thyroid gland, gradually impairing its ability to produce hormones and leading to fatigue, brain fog, weight gain, and cold intolerance. While thyroid hormone replacement is often necessary, there is solid clinical evidence that selenium, vitamin D, myo-inositol, and certain dietary changes can meaningfully reduce the autoimmune attack and support thyroid function alongside — or before — medication [1][2]. ## What Is Hashimoto's Thyroiditis? Hashimoto's is an autoimmune thyroiditis in which the immune system produces antibodies against thyroid peroxidase (TPO-Ab) and thyroglobulin (TgAb). These antibodies drive chronic inflammation in the thyroid gland, slowly destroying thyroid tissue. Over time, many people develop hypothyroidism (underactive thyroid), though some cycle through periods of hyperthyroid symptoms as damaged tissue releases stored hormone. Diagnosis is typically confirmed by elevated TPO antibodies on a blood test, often combined with thyroid ultrasound showing a heterogeneous (patchy) texture. TSH may be elevated (indicating the pituitary is pushing hard to compensate), though many people with active Hashimoto's have TSH in the "normal" range early in the disease. The goal of natural management is not to cure an autoimmune condition — that is not possible — but to reduce the intensity of the autoimmune attack, lower antibody levels, preserve thyroid tissue, and prevent or delay the progression to overt hypothyroidism. ## Selenium: The Best-Studied Supplement for Hashimoto's The thyroid gland contains the highest concentration of selenium of any organ in the body. Selenium is required for the activity of glutathione peroxidase (an antioxidant enzyme that neutralizes hydrogen peroxide produced during thyroid hormone synthesis) and for the deiodinase enzymes that convert T4 to active T3. In Hashimoto's, selenium deficiency allows oxidative damage to accumulate in thyroid tissue, worsening inflammation. A 2024 systematic review and meta-analysis — the most comprehensive to date — pooled data from 29 cohorts with 2,358 participants and found that selenium supplementation significantly reduced TPO-Ab levels in patients both on and off thyroid hormone replacement therapy [1]. In patients not yet on thyroid hormone replacement, selenium also reduced TSH, suggesting preserved thyroid function. The effect was consistent across formulations (selenomethionine, sodium selenite) and dosages. **Practical guidance:** 100–200 mcg/day of selenomethionine is the most studied dose. Brazil nuts provide variable selenium (one nut contains roughly 50–90 mcg, though soil selenium content varies widely). Because selenium is toxic in excess, supplementation should be guided by blood testing — optimal serum selenium is approximately 120–150 mcg/L. ## Myo-Inositol: A Promising Combination Partner Myo-inositol is a naturally occurring sugar alcohol found in fruits, legumes, and nuts. In the thyroid, it serves as a secondary messenger in the TSH signaling cascade — it helps the thyroid respond appropriately to TSH stimulation. Research has found that combining myo-inositol with selenium produces better results than selenium alone. Two clinical trials by Nordio and colleagues found that 600 mg/day of myo-inositol combined with 83 mcg/day of selenium significantly reduced TSH, TPO-Ab, and TgAb after six months compared to selenium alone, and restored normal thyroid function in a substantial proportion of subclinical hypothyroid patients [3][6]. The combination appears to work through complementary mechanisms: selenium reduces oxidative damage and autoimmune intensity, while myo-inositol improves TSH sensitivity and hormone synthesis efficiency. **Practical guidance:** Supplements combining myo-inositol (600 mg) and selenium (83–100 mcg) are available as thyroid-specific formulas. This approach is particularly relevant for people with subclinical hypothyroidism (TSH 3–6 mIU/L) who are not yet on thyroid hormone replacement. ## Vitamin D: Immune Regulation and Antibody Reduction Vitamin D deficiency is significantly more common in people with Hashimoto's than in the general population, and low vitamin D correlates with higher antibody levels and more severe disease. Vitamin D receptors are expressed on nearly all immune cells; adequate vitamin D promotes T-regulatory cell activity, which restrains the autoimmune attack on the thyroid. A 2023 meta-analysis of 12 randomized controlled trials with 862 participants found that vitamin D supplementation significantly reduced TPO-Ab titers (standardized mean difference: -1.084, 95% CI: -1.624 to -0.545) [2]. A separate 2023 RCT with 179 patients in China found that vitamin D supplementation slowed progression of hypothyroidism and reduced both TPO-Ab and TgAb levels over 12 months [5]. **Practical guidance:** Get your 25-OH vitamin D tested. Most Hashimoto's practitioners aim for levels of 50–70 ng/mL (125–175 nmol/L), which requires supplementation beyond standard doses for most people. 3,000–5,000 IU/day of vitamin D3 with vitamin K2 (to direct calcium) is commonly used. See our [Vitamin D page](/vitamin-d/sunshine-vitamin) for more detail. ## Gluten-Free Diet: Relevant for Some, Not All The relationship between Hashimoto's and gluten is a nuanced one. Celiac disease (an autoimmune reaction to gluten) co-occurs with Hashimoto's more often than chance would predict — likely because both conditions share immune-mediated pathways. For people with both conditions, a strict gluten-free diet reduces thyroid antibodies by resolving intestinal inflammation and reducing leaky gut. For Hashimoto's patients without celiac disease, the evidence is mixed but suggestive. A pilot study by Krysiak et al. found that a 6-month gluten-free diet in 34 drug-naive women with Hashimoto's (none with celiac disease) significantly reduced TPO-Ab and TgAb levels, as well as fasting insulin and homocysteine, compared to controls [4]. However, larger controlled trials have not consistently replicated this finding. **Practical guidance:** A 3–6 month trial of strict gluten elimination is reasonable for anyone with Hashimoto's who has digestive symptoms, other inflammatory conditions, or who suspects gluten sensitivity. Test for celiac disease (anti-tTG IgA) before going gluten-free, as gluten removal falsely normalizes the test. Even if celiac is absent, a gluten-free trial can be informative. See our [Gluten Sensitivity page](/gluten-sensitivity) and [Leaky Gut page](/leaky-gut) for more. ## Dietary Principles for Hashimoto's Beyond gluten, broader dietary patterns influence autoimmune activity through gut health, inflammation, and oxidative stress: - **Anti-inflammatory foods:** olive oil, fatty fish (salmon, sardines, mackerel), colorful vegetables, berries, and leafy greens reduce pro-inflammatory cytokines - **Iodine in moderation:** iodine is essential for thyroid hormone production, but excess iodine (from seaweed supplements, high-dose iodine supplements, or iodine-based contrast dyes) can trigger Hashimoto's flares by increasing thyroid peroxidase activity and hydrogen peroxide generation — the combination is particularly damaging when selenium is deficient - **Fermented foods:** support a diverse gut microbiome, which modulates systemic immune tone — see our [Fermented Foods page](/fermented-foods/living-foods) for options - **Goitrogens (a nuanced topic):** raw cruciferous vegetables contain glucosinolates that can mildly inhibit iodine uptake at very high intakes; for most people with adequate iodine, moderate cooked cruciferous vegetable consumption is safe and beneficial ## Other Supportive Strategies - **Stress management:** the HPA axis and immune system are intimately connected; chronic stress increases inflammatory cytokines and can trigger autoimmune flares. Yoga, meditation, and adequate sleep are all relevant — see our [Cortisol page](/cortisol) - **Magnesium:** deficiency is common in autoimmune conditions and worsens inflammation — see our [Magnesium page](/magnesium/why-magnesium-matters) - **Avoiding endocrine disruptors:** phthalates, BPA, and PFAS compounds interfere with thyroid hormone signaling — see our [Phthalates page](/phthalates) and [PFAS page](/pfas) - **Supporting gut health:** leaky gut may allow antigenic material to drive immune reactivity; L-glutamine, probiotics, and fiber support intestinal barrier integrity — see our [Leaky Gut page](/leaky-gut) ## Evidence Review ### Selenium Meta-Analysis (Huwiler et al., 2024) The 2024 meta-analysis by Huwiler and colleagues (PMID 38243784) is the most comprehensive systematic review of selenium supplementation in Hashimoto's thyroiditis to date, pooling data from 29 cohorts with 2,358 participants from randomized clinical trials. The primary finding was a significant reduction in TPO-Ab levels across participants both on and off thyroid hormone replacement therapy. In the subgroup not on thyroid hormone replacement (7 cohorts, 869 participants), selenium supplementation also significantly reduced TSH levels, indicating a functional benefit to thyroid gland output rather than just immunological markers. Secondary outcomes included reduced MDA (malondialdehyde, a marker of oxidative stress) and improved patient-reported quality of life in some trials. Dose ranged from 100 to 200 mcg/day, with selenomethionine and sodium selenite both showing effects. Duration ranged from 3 to 12 months. Adverse events were minimal and not significantly different from placebo at these doses. **Strength of evidence:** High. This is a large, well-conducted meta-analysis of randomized trials. The primary limitation is heterogeneity in how TPO-Ab levels were measured across trials (different assays and units), which the authors addressed using standardized mean differences. The reduction in antibody levels is clinically meaningful — lower TPO-Ab is associated with slower thyroid tissue destruction and reduced symptom burden. ### Myo-Inositol Plus Selenium (Nordio & Basciani, 2017) The 2017 randomized controlled trial by Nordio and Basciani (PMID 28724185) enrolled 168 patients with Hashimoto's thyroiditis and TSH levels between 3 and 6 µIU/mL (subclinical hypothyroidism). Patients were randomized to receive either myo-inositol 600 mg plus selenium 83 mcg/day or selenium alone for six months. At six months, TSH, TPO-Ab, and TgAb were all significantly lower in the combination group compared to the selenium-only group. A substantial proportion of combination-treated patients normalized their TSH, compared to a smaller proportion in the selenium-only group. These results build on an earlier pilot by Nordio and Pajalich (PMID 24224112), which found similar benefits in 36 subclinical hypothyroid patients over six months. The proposed mechanism is complementary: selenium reduces oxidative damage and inflammation that drives the autoimmune attack, while myo-inositol improves TSH signaling efficiency within thyroid follicular cells, reducing the TSH burden required to maintain hormone output and allowing the gland to function more normally. **Strength of evidence:** Moderate. The trials are adequately powered and well-designed, but conducted by the same research group and have not been independently replicated in large trials. Effect sizes are clinically meaningful. A 2024 systematic review and meta-analysis pooled three studies (151 participants on selenium plus myo-inositol and 137 on selenium alone) and found a significantly larger fall in TSH (standardized mean difference −1.15, 95% CI −1.60 to −0.69) and in thyroglobulin antibodies, but not in TPO antibodies, T3, or T4. It included observational studies as well as randomized trials, and its authors called for adequately powered trials with longer follow-up [7]. ### Vitamin D Supplementation Meta-Analysis (Tang et al., 2023) The 2023 meta-analysis by Tang et al. (PMID 38206745) included 12 randomized controlled trials with 862 participants, making it the largest meta-analysis of vitamin D supplementation specifically in Hashimoto's patients. The primary outcome — change in TPO-Ab — showed a statistically significant reduction with vitamin D supplementation (SMD = -1.084, 95% CI: -1.624 to -0.545, p < 0.001). The analysis also found significant reductions in TgAb and modest improvements in TSH in some subgroups. Benefit was most pronounced in patients who were vitamin D deficient at baseline, suggesting that correcting deficiency rather than mega-dosing is the relevant mechanism. A concurrent Chinese RCT (PMID 37969187) by Jiang et al. enrolled 179 patients randomized to vitamin D supplementation or control, with 12 months of follow-up. The treatment group showed significantly lower anti-thyroid antibody levels and slower progression of hypothyroidism as assessed by TSH trajectory. This is one of the few trials to demonstrate a clinically meaningful endpoint (disease progression) rather than only biomarker changes. **Strength of evidence:** Moderate-high. The meta-analysis has good statistical power. Key limitations include heterogeneity in vitamin D dosing (ranging from 1,200 to 50,000 IU/week) and baseline vitamin D levels across trials, making dose-response relationships unclear. The consistent directionality across studies and the plausible mechanistic pathway (vitamin D → Treg upregulation → reduced autoimmune attack) strengthens the overall case. ### Gluten-Free Diet Pilot Study (Krysiak et al., 2019) The 2019 pilot by Krysiak and colleagues (PMID 30060266) enrolled 34 drug-naive women with Hashimoto's thyroiditis, none of whom had celiac disease by serology or histology. Sixteen women adhered to a strict gluten-free diet for 6 months; 18 served as untreated controls. At 6 months, the gluten-free group showed significant reductions in TPO-Ab and TgAb levels, as well as significant reductions in fasting insulin and homocysteine — both markers relevant to metabolic and cardiovascular risk in Hashimoto's patients. TSH did not change significantly. The mechanistic hypothesis is that gluten induces intestinal permeability (leaky gut) in susceptible individuals, allowing antigens to cross the intestinal barrier and drive systemic immune activation, including autoimmune thyroiditis. Removing gluten reduces this antigenic burden. An alternative or complementary explanation is that whole food gluten-free diets tend to reduce processed food and refined carbohydrate intake, improving gut microbiome composition and reducing systemic inflammation regardless of gluten per se. **Strength of evidence:** Low-moderate. This is a small pilot study (n=34) without randomization — participants self-selected into the dietary group. Larger, properly randomized trials are needed. A 2023 meta-analysis of four studies with 87 patients who had Hashimoto's thyroiditis but no symptoms or biopsy evidence of celiac disease (Piticchio et al.) found that a gluten-free diet lasting about six months was associated with a lower TSH and a higher free T4, while the falls in thyroid antibodies were not statistically significant (thyroglobulin antibodies p = 0.06, TPO antibodies p = 0.07). The benefit seemed greater in patients with other gluten-related conditions, and the authors judged the evidence not yet sufficient to recommend the diet to all patients with Hashimoto's [8]. A gluten-free trial is reasonable to attempt but should not be expected to produce dramatic results in all patients.